SECTOR GAMMA AS Diversified Active

Location: Oslo, Norway

CIK: 0001475373 · Show all filings

Period: Q2 2026 (← Previous)

Filing Date: Aug 12, 2026

Total Value: $461M (100.0% shares, 0.0% debt)

Holdings (40)

New Positions (7)

Increased Positions (19)

IQV IQVIA HLDGS INC 3.3%
Value $15.06M (+119.5%) Shares 77,944 (+93.7%) Share Price $193.22 Est. Cost/Share $201.96 Unrealized @ Report Date —
CVS CVS HEALTH CORP 3.5%
Value $16.07M (+65.3%) Shares 155,337 (+14.8%) Share Price $103.45 Est. Cost/Share $70.44 Unrealized @ Report Date —
QGEN QIAGEN NV 2.4%
Value $11.25M (+73.0%) Shares 287,640 (+77.1%) Share Price $39.10 Est. Cost/Share $45.43 Unrealized @ Report Date —
ABT ABBOTT LABS 2.9%
Value $13.38M (+48.9%) Shares 147,444 (+68.4%) Share Price $90.74 Est. Cost/Share $105.39 Unrealized @ Report Date —
ELV ELEVANCE HEALTH INC FORMERLY 3.7%
Value $17.21M (+33.7%) Shares 44,499 (+1.2%) Share Price $386.73 Est. Cost/Share $351.64 Unrealized @ Report Date —
GEHC GE HEALTHCARE TECHNOLOGIES I 2.9%
Value $13.31M (+47.9%) Shares 207,863 (+64.4%) Share Price $64.01 Est. Cost/Share $71.80 Unrealized @ Report Date —
AVTR AVANTOR INC 1.9%
Value $8.97M (+64.5%) Shares 906,088 (+30.3%) Share Price $9.90 Est. Cost/Share $12.38 Unrealized @ Report Date —
DXCM DEXCOM INC 1.5%
Value $6.878M (+95.1%) Shares 102,122 (+82.0%) Share Price $67.35 Est. Cost/Share $73.56 Unrealized @ Report Date —
BMRN BIOMARIN PHARMACEUTICAL INC 3.7%
Value $16.88M (+24.5%) Shares 294,918 (+22.9%) Share Price $57.22 Est. Cost/Share $67.57 Unrealized @ Report Date —
MDT MEDTRONIC PLC 6.0%
Value $27.57M (+13.4%) Shares 352,437 (+25.6%) Share Price $78.23 Est. Cost/Share $83.12 Unrealized @ Report Date —
BIO BIO RAD LABS INC 2.1%
Value $9.792M (+47.9%) Shares 33,350 (+40.4%) Share Price $293.61 Est. Cost/Share $294.17 Unrealized @ Report Date —
PTCT PTC THERAPEUTICS INC 1.8%
Value $8.157M (+59.6%) Shares 100,000 (+33.3%) Share Price $81.57 Est. Cost/Share $58.80 Unrealized @ Report Date —
IONS IONIS PHARMACEUTICALS INC 3.3%
Value $15.02M (+18.1%) Shares 189,468 (+11.8%) Share Price $79.29 Est. Cost/Share $49.60 Unrealized @ Report Date —
LH LABCORP HOLDINGS INC 1.6%
Value $7.285M (+43.6%) Shares 26,019 (+36.8%) Share Price $280.00 Est. Cost/Share $257.11 Unrealized @ Report Date —
KURA KURA ONCOLOGY INC 1.0%
Value $4.75M (+41.9%) Shares 433,012 (+5.1%) Share Price $10.97 Est. Cost/Share $7.44 Unrealized @ Report Date —
BDX BECTON DICKINSON & CO 3.1%
Value $14.1M (+8.5%) Shares 93,168 (+12.8%) Share Price $151.33 Est. Cost/Share $204.75 Unrealized @ Report Date —
IOVA IOVANCE BIOTHERAPEUTICS INC 0.9%
Value $4.029M (+27.5%) Shares 968,466 (+7.6%) Share Price $4.16 Est. Cost/Share $2.78 Unrealized @ Report Date —
CRNX CRINETICS PHARMACEUTICALS IN 0.9%
Value $4.289M (+25.4%) Shares 114,628 (+21.7%) Share Price $37.42 Est. Cost/Share $43.25 Unrealized @ Report Date —
ARDX ARDELYX INC 0.8%
Value $3.503M (+13.3%) Shares 686,844 (+33.1%) Share Price $5.10 Est. Cost/Share $6.58 Unrealized @ Report Date —

Exited Positions (9)

Decreased Positions (11)

BMY BRISTOL-MYERS SQUIBB CO 9.1%
Value $41.84M (-16.7%) Shares 726,115 (-12.3%) Share Price $57.62 Est. Cost/Share $49.36 Unrealized @ Report Date —
AMGN AMGEN INC 2.1%
Value $9.517M (-42.6%) Shares 26,281 (-44.3%) Share Price $362.12 Est. Cost/Share $285.08 Unrealized @ Report Date —
PFE PFIZER INC 5.2%
Value $24.18M (-21.1%) Shares 1,004,215 (-8.0%) Share Price $24.08 Est. Cost/Share $25.58 Unrealized @ Report Date —
BIIB BIOGEN INC 2.5%
Value $11.7M (-29.2%) Shares 54,163 (-39.9%) Share Price $216.06 Est. Cost/Share $165.19 Unrealized @ Report Date —
MRK MERCK & CO INC 6.0%
Value $27.89M (-11.0%) Shares 217,008 (-16.6%) Share Price $128.50 Est. Cost/Share $80.39 Unrealized @ Report Date —
CAH CARDINAL HEALTH INC 2.1%
Value $9.666M (-16.7%) Shares 40,689 (-25.9%) Share Price $237.56 Est. Cost/Share $64.47 Unrealized @ Report Date —
ZBH ZIMMER BIOMET HOLDINGS INC 2.7%
Value $12.25M (-13.1%) Shares 142,307 (-8.7%) Share Price $86.09 Est. Cost/Share $104.78 Unrealized @ Report Date —
OGN ORGANON & CO 0.8%
Value $3.666M (+62.8%) Shares 270,781 (-28.0%) Share Price $13.54 Est. Cost/Share $9.46 Unrealized @ Report Date —
SNDX SYNDAX PHARMACEUTICALS INC 1.1%
Value $5.284M (-20.9%) Shares 241,739 (-15.5%) Share Price $21.86 Est. Cost/Share $14.63 Unrealized @ Report Date —
INCY INCYTE CORP 4.2%
Value $19.36M (+2.6%) Shares 170,753 (-14.8%) Share Price $113.36 Est. Cost/Share $71.18 Unrealized @ Report Date —
BRKR BRUKER CORP 2.0%
Value $9.169M (-0.1%) Shares 152,352 (-40.0%) Share Price $60.18 Est. Cost/Share $51.49 Unrealized @ Report Date —